IBDEI3AG ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,52483,0)
;;=E10.65^^194^2539^14
;;^UTILITY(U,$J,358.3,52483,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52483,1,3,0)
;;=3^DM Type 1 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,52483,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,52483,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,52484,0)
;;=E10.69^^194^2539^29
;;^UTILITY(U,$J,358.3,52484,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52484,1,3,0)
;;=3^DM Type 1 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,52484,1,4,0)
;;=4^E10.69
;;^UTILITY(U,$J,358.3,52484,2)
;;=^5002624
;;^UTILITY(U,$J,358.3,52485,0)
;;=E10.8^^194^2539^33
;;^UTILITY(U,$J,358.3,52485,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52485,1,3,0)
;;=3^DM Type 1 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,52485,1,4,0)
;;=4^E10.8
;;^UTILITY(U,$J,358.3,52485,2)
;;=^5002625
;;^UTILITY(U,$J,358.3,52486,0)
;;=E10.9^^194^2539^34
;;^UTILITY(U,$J,358.3,52486,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52486,1,3,0)
;;=3^DM Type 1 w/o Compl
;;^UTILITY(U,$J,358.3,52486,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,52486,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,52487,0)
;;=E10.620^^194^2539^5
;;^UTILITY(U,$J,358.3,52487,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52487,1,3,0)
;;=3^DM Type 1 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,52487,1,4,0)
;;=4^E10.620
;;^UTILITY(U,$J,358.3,52487,2)
;;=^5002615
;;^UTILITY(U,$J,358.3,52488,0)
;;=E10.36^^194^2539^4
;;^UTILITY(U,$J,358.3,52488,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52488,1,3,0)
;;=3^DM Type 1 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,52488,1,4,0)
;;=4^E10.36
;;^UTILITY(U,$J,358.3,52488,2)
;;=^5002602
;;^UTILITY(U,$J,358.3,52489,0)
;;=E10.621^^194^2539^6
;;^UTILITY(U,$J,358.3,52489,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52489,1,3,0)
;;=3^DM Type 1 w/ Diab Foot Ulcer
;;^UTILITY(U,$J,358.3,52489,1,4,0)
;;=4^E10.621
;;^UTILITY(U,$J,358.3,52489,2)
;;=^5002616
;;^UTILITY(U,$J,358.3,52490,0)
;;=E10.622^^194^2539^28
;;^UTILITY(U,$J,358.3,52490,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52490,1,3,0)
;;=3^DM Type 1 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,52490,1,4,0)
;;=4^E10.622
;;^UTILITY(U,$J,358.3,52490,2)
;;=^5002617
;;^UTILITY(U,$J,358.3,52491,0)
;;=E10.51^^194^2539^32
;;^UTILITY(U,$J,358.3,52491,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52491,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,52491,1,4,0)
;;=4^E10.51
;;^UTILITY(U,$J,358.3,52491,2)
;;=^5002610
;;^UTILITY(U,$J,358.3,52492,0)
;;=E10.52^^194^2539^31
;;^UTILITY(U,$J,358.3,52492,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52492,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,52492,1,4,0)
;;=4^E10.52
;;^UTILITY(U,$J,358.3,52492,2)
;;=^5002611
;;^UTILITY(U,$J,358.3,52493,0)
;;=E11.00^^194^2540^19
;;^UTILITY(U,$J,358.3,52493,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52493,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
;;^UTILITY(U,$J,358.3,52493,1,4,0)
;;=4^E11.00
;;^UTILITY(U,$J,358.3,52493,2)
;;=^5002627
;;^UTILITY(U,$J,358.3,52494,0)
;;=E11.01^^194^2540^18
;;^UTILITY(U,$J,358.3,52494,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52494,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
;;^UTILITY(U,$J,358.3,52494,1,4,0)
;;=4^E11.01
;;^UTILITY(U,$J,358.3,52494,2)
;;=^5002628
;;^UTILITY(U,$J,358.3,52495,0)
;;=E11.21^^194^2540^7
;;^UTILITY(U,$J,358.3,52495,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3AG 3791 printed Dec 13, 2024@02:44:57 Page 2
IBDEI3AG ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,52483,0)
+2 ;;=E10.65^^194^2539^14
+3 ;;^UTILITY(U,$J,358.3,52483,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,52483,1,3,0)
+6 ;;=3^DM Type 1 w/ Hyperglycemia
+7 ;;^UTILITY(U,$J,358.3,52483,1,4,0)
+8 ;;=4^E10.65
+9 ;;^UTILITY(U,$J,358.3,52483,2)
+10 ;;=^5002623
+11 ;;^UTILITY(U,$J,358.3,52484,0)
+12 ;;=E10.69^^194^2539^29
+13 ;;^UTILITY(U,$J,358.3,52484,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,52484,1,3,0)
+16 ;;=3^DM Type 1 w/ Oth Spec Compl
+17 ;;^UTILITY(U,$J,358.3,52484,1,4,0)
+18 ;;=4^E10.69
+19 ;;^UTILITY(U,$J,358.3,52484,2)
+20 ;;=^5002624
+21 ;;^UTILITY(U,$J,358.3,52485,0)
+22 ;;=E10.8^^194^2539^33
+23 ;;^UTILITY(U,$J,358.3,52485,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,52485,1,3,0)
+26 ;;=3^DM Type 1 w/ Unspec Compl
+27 ;;^UTILITY(U,$J,358.3,52485,1,4,0)
+28 ;;=4^E10.8
+29 ;;^UTILITY(U,$J,358.3,52485,2)
+30 ;;=^5002625
+31 ;;^UTILITY(U,$J,358.3,52486,0)
+32 ;;=E10.9^^194^2539^34
+33 ;;^UTILITY(U,$J,358.3,52486,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,52486,1,3,0)
+36 ;;=3^DM Type 1 w/o Compl
+37 ;;^UTILITY(U,$J,358.3,52486,1,4,0)
+38 ;;=4^E10.9
+39 ;;^UTILITY(U,$J,358.3,52486,2)
+40 ;;=^5002626
+41 ;;^UTILITY(U,$J,358.3,52487,0)
+42 ;;=E10.620^^194^2539^5
+43 ;;^UTILITY(U,$J,358.3,52487,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,52487,1,3,0)
+46 ;;=3^DM Type 1 w/ Diab Dermatitis
+47 ;;^UTILITY(U,$J,358.3,52487,1,4,0)
+48 ;;=4^E10.620
+49 ;;^UTILITY(U,$J,358.3,52487,2)
+50 ;;=^5002615
+51 ;;^UTILITY(U,$J,358.3,52488,0)
+52 ;;=E10.36^^194^2539^4
+53 ;;^UTILITY(U,$J,358.3,52488,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,52488,1,3,0)
+56 ;;=3^DM Type 1 w/ Diab Cataract
+57 ;;^UTILITY(U,$J,358.3,52488,1,4,0)
+58 ;;=4^E10.36
+59 ;;^UTILITY(U,$J,358.3,52488,2)
+60 ;;=^5002602
+61 ;;^UTILITY(U,$J,358.3,52489,0)
+62 ;;=E10.621^^194^2539^6
+63 ;;^UTILITY(U,$J,358.3,52489,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,52489,1,3,0)
+66 ;;=3^DM Type 1 w/ Diab Foot Ulcer
+67 ;;^UTILITY(U,$J,358.3,52489,1,4,0)
+68 ;;=4^E10.621
+69 ;;^UTILITY(U,$J,358.3,52489,2)
+70 ;;=^5002616
+71 ;;^UTILITY(U,$J,358.3,52490,0)
+72 ;;=E10.622^^194^2539^28
+73 ;;^UTILITY(U,$J,358.3,52490,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,52490,1,3,0)
+76 ;;=3^DM Type 1 w/ Oth Skin Ulcer
+77 ;;^UTILITY(U,$J,358.3,52490,1,4,0)
+78 ;;=4^E10.622
+79 ;;^UTILITY(U,$J,358.3,52490,2)
+80 ;;=^5002617
+81 ;;^UTILITY(U,$J,358.3,52491,0)
+82 ;;=E10.51^^194^2539^32
+83 ;;^UTILITY(U,$J,358.3,52491,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,52491,1,3,0)
+86 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
+87 ;;^UTILITY(U,$J,358.3,52491,1,4,0)
+88 ;;=4^E10.51
+89 ;;^UTILITY(U,$J,358.3,52491,2)
+90 ;;=^5002610
+91 ;;^UTILITY(U,$J,358.3,52492,0)
+92 ;;=E10.52^^194^2539^31
+93 ;;^UTILITY(U,$J,358.3,52492,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,52492,1,3,0)
+96 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
+97 ;;^UTILITY(U,$J,358.3,52492,1,4,0)
+98 ;;=4^E10.52
+99 ;;^UTILITY(U,$J,358.3,52492,2)
+100 ;;=^5002611
+101 ;;^UTILITY(U,$J,358.3,52493,0)
+102 ;;=E11.00^^194^2540^19
+103 ;;^UTILITY(U,$J,358.3,52493,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,52493,1,3,0)
+106 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
+107 ;;^UTILITY(U,$J,358.3,52493,1,4,0)
+108 ;;=4^E11.00
+109 ;;^UTILITY(U,$J,358.3,52493,2)
+110 ;;=^5002627
+111 ;;^UTILITY(U,$J,358.3,52494,0)
+112 ;;=E11.01^^194^2540^18
+113 ;;^UTILITY(U,$J,358.3,52494,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,52494,1,3,0)
+116 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
+117 ;;^UTILITY(U,$J,358.3,52494,1,4,0)
+118 ;;=4^E11.01
+119 ;;^UTILITY(U,$J,358.3,52494,2)
+120 ;;=^5002628
+121 ;;^UTILITY(U,$J,358.3,52495,0)
+122 ;;=E11.21^^194^2540^7
+123 ;;^UTILITY(U,$J,358.3,52495,1,0)
+124 ;;=^358.31IA^4^2
